GlassScriptPhysician profile
Don Max Thrower
NPI 1598747438
$3,777.15
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,410 · 2022: $1,368.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $646.58 | 2021-2022 | |
| Novo Nordisk INC | $623.00 | 2021-2022 | |
| Abbvie INC. | $446.68 | 2021-2022 | |
| Corcept Therapeutics | $254.21 | 2021-2022 | |
| Abbott Laboratories | $239.82 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $203.56 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.50 | 2021-2022 | |
| Lifescan, INC. | $159.60 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.34 | 2021-2022 | |
| Amarin Pharma, INC. | $153.96 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $103.49 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $77.98 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $68.82 | 2021-2022 | |
| Ibsa Pharma INC. | $60.87 | 2021 | |
| Amgen INC. | $59.98 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $45.31 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $43.64 | 2021 | |
| Dexcom, INC. | $40.40 | 2021 | |
| Alexion Pharmaceuticals, INC. | $35.83 | 2021 | |
| Zealand Pharma US, INC. | $26.68 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $22.05 | 2022 | |
| Mannkind Corporation | $21.92 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.30 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $17.23 | 2021 | |
| Biogen, INC. | $16.63 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.61 | 2022 | |
| Astellas Pharma US INC | $14.24 | 2021 | |
| Pfizer INC. | $13.32 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.66 | 2021 | |
| Merck Sharp & Dohme LLC | $11.94 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Thrower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.